LIMK1 and fragile X syndrome: We hope thatthe developed tool compounds will help to further elucidate the detailedroles of LIMK1-specific signaling and may serve as a starting pointfor the treatment of Fragile X syndrome, in which LIMK1 activity isselectively upregulated.